Background: Mucosally transmitted founder (TF) HIV-1 are more resistant to the antiviral effects of type 1 interferons (IFNs) than viruses that predominate during chronic infection. To determine whether IFN-resistant viruses are specifically selected for during HIV-1 transmission, we derived viral isolates by limiting dilution from both plasma and genital fluids of chronically infected transmission donors and examined their relative IFN resistance.
Methods: Plasma and cervicovaginal lavage (CVL) were collected from the donors of epidemiologically linked transmission pairs. Plasma or the non-cellular fraction of CVL samples were incubated with activated CD4+ T-cells to generate limiting-dilution isolates. Half genome sequences were analyzed to characterize the extent of genetic diversity. IFNα sensitivity of each isolate was analyzed by determining the IC50 in primary CD4+ T-cells.
Results: We first used plasma from patient CH212 to determine that 500-1000 vRNA copies were required to obtain limiting dilution isolates. The diversity among 18 CH212 isolates was 2.5%, comparable to that observed by SGS analysis of the plasma vRNA. We determined the IFNα sensitivity of each virus isolate. IC50 values ranged from 8 to 115 U/ml and were significantly lower than the IC50 value of the TF virus (240 U/ml) of the CH162 recipient. In an attempt to isolate IFNα-resistant viruses from the plasma, the limiting dilution isolation method was repeated in the presence of IFNα. The IFNα IC50 values of the 5 new isolates ranged from 155 to 225 U/ml, revealing that IFNα resistant viruses are present, but infrequent, in the donor plasma. We next obtained limiting-dilution isolates from plasma (n=10) and matching CVL (n=10) from donor CH492. The mean genetic diversity and the mean IFNα IC50 values were comparable between isolates derived from plasma and genital secretions. Interestingly, one CVL-derived isolate had a significantly higher IFNα IC50 value and was genetically most closely related to the single TF identified in the CH427 recipient.
Conclusions: Viruses circulating in plasma and sexual secretions of chronically infected individuals exhibit a wide range of IFN resistance, and are generally more IFN sensitive than TF viruses that establish de novo infections. However, some donor viruses exhibit elevated resistance to IFNα and seem to be those that are preferentially transmitted. Thus, IFN-resistant viruses are specifically selected from a pool of biologically diverse viruses during mucosal HIV-1 transmission.